- Investing Ideas
- South Korean Pharmaceuticals & Biotech High Return On Equity, Low Debt
South Korean Pharmaceuticals & Biotech High Return On Equity, Low Debt
Results
4
Stocks with a return on equity of over 30% and a debt to equity ratio below 1.
4 companies
SK Biopharmaceuticals
Market Cap: ₩6.8t
A pharmaceutical company, engages in the research, development, and commercialization of drugs for the treatment of central nervous system disorders.
A326030
₩87,000.00
7D
-1.0%
1Y
-6.4%
Oscotec
Market Cap: ₩1.4t
Operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses.
A039200
₩37,150.00
7D
-5.0%
1Y
31.3%
JW Shinyak
Market Cap: ₩130.5b
Engages in the research, development, production, and sale of medicines and medical supplies in South Korea.
A067290
₩2,335.00
7D
70.9%
1Y
43.7%
DongKoo Bio & Pharma
Market Cap: ₩106.0b
Manufactures and sells pharmaceuticals in South Korea.
A006620
₩3,920.00
7D
-5.7%
1Y
-28.5%